Delivery Order SPE2DR25D7059-SPE2DR26F7MDC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Levothyroxine 200 mcg tablets in quantities of 1,000 units, with a ceiling value of $13,837.62. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for ultimate completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Levothyroxine 100 mcg/ml vials under a firm fixed-price contract valued at $2,015.19, with completion expected by October 20, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.56 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 25 MCG tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with no set-aside designation, issued competitively on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- This federal contract award is a delivery order with a firm fixed price valued at $1,167.18, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 4,565,749,812 units of Levothyroxine 50 MCG Tablets, a medication used to treat hypothyroidism. The ultimate completion date for this delivery order is September 11, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- The Defense Logistics Agency awarded a $11,490 delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 100 microgram Levothyroxine tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning from July 28 to July 31, 2023. Levothyroxine is a prescription medication used to treat an underactive thyroid. This delivery order was issued against an existing DLA pharmaceutical supply contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 30, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,723.68 with an ultimate completion date of September 2, 2025, represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office...
- This federal contract award, valued at $2,922.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of levothyroxin 100mcg tablets, a medication used to treat hypothyroidism, with a performance period through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $8,598.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Levothyroxine 125 mcg tablets, a medication used to treat thyroid disorders. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $73,400 to Amerisourcebergen Drug Corporation for the supply of 112 microgram levothyroxine tablets. Under the terms of the award, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania, with performance required between August 3rd and 4th of 2023. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will fulfill the order in support of the Defense Logistics Agency's...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MDCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Levothyroxine 200 micrograms, valued at $1,047.02 under a firm fixed-price contract type. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025. This is an unset-aside competitive award, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Levothyroxine is a synthetic thyroid hormone commonly used to treat hypothyroidism and other thyroid conditions across military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's established role as a major pharmaceutical distributor and critical federal medical procurement vendor positions it to fulfill ongoing Defense Health Agency and U.S. military healthcare requirements through this flexible contracting arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/20/25 |